Deepbridge shortlisted for 5 awards
Deepbridge has been shortlisted in the following five categories at this year’s Growth Investor Awards, taking place on the 6th November 2019:
REQUEST E-APPLICATION FORM | 01244 746000 | Log in
Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.
Investments in unquoted companies carry high risks and investors could lose all funds invested. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. Investors are encouraged to take independent legal, tax and financial advice before considering an investment.
By clicking below, you confirm that you are an FCA authorised firm or individual and agree to be directed to our website, which is for FCA authorised firms and individuals only. Persons who do not meet this classification should leave this page.
If you are not a professional financial adviser, please contact the Deepbridge Investor Relations Team on 01244 746000 or by email at enquiries@deepbridgecapital.com.
Deepbridge has been shortlisted in the following five categories at this year’s Growth Investor Awards, taking place on the 6th November 2019:
Glyconics, which is part of the Deepbridge Life Sciences EIS portfolio, is one of the final five companies that have been selected for the East of England Investment Catalyst.
arbnco, which is part of the Deepbridge Technology Growth EIS portfolio, is the only Scottish company to be awarded phase one funding to develop a Digital Energy Efficiency Platform (DEEP) to improve energy efficiency across SMEs in the UK.
We are pleased to announce that Deepbridge has beaten off tough competition to win the award for ‘Best SEIS Investment Manager’ at this year’s Growth Investor Awards, as well as being labelled ‘one to watch’ in the ‘Best EIS Investment Manager’ category.
Hurricane, which is part of the Deepbridge Technology Growth EIS portfolio, has announced a new partnership with Australia Post, which is the government-owned corporation that provides postal services in Australia.
Pacla Medical, which is part of the Deepbridge Life Sciences EIS portfolio, has developed 'BackHug', which is a physiotherapy massage device that uses "robo-finger" technology.
Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
1. You could lose all the money you invest
2. You are unlikely to be protected if something goes wrong
3. You won’t get your money back quickly
4. Don’t put all your eggs in one basket
5. The value of your investment can be reduced
If you are interested in learning more about how to protect yourself, visit the FCA’s website here. [https://www.fca.org.uk/investsmart]